Cytos Biotechnology Aktie
WKN: A2ALS5
ISIN: CH0325814116
Land: Schweiz
Branche: Chemie, Pharma, Bio- & Medizintechnik
Sektor: Biotechnologie
Gratis: Die zehn beliebtesten Rüstungs-Aktien im Check! Info...
29,60 EUR 0,00 EUR 0,00 %
13:02:27 L&S RT
Komplette Navigation anzeigen

News und Analysen

Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division

Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division

Kuros Biosciences AG / Key word(s): Agreement Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division 07-Jan-2025 / 07:00 CET/CEST Release ...weiterlesen

10.10.24
Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024
08.08.24
Kuros Biosciences Reports First Half of 2024 Results
25.06.24
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
24.04.24
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
17.04.24
Annual General Meeting of Kuros Biosciences approves all resolutions
13.03.24
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
08.03.24
Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
01.02.24
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
31.01.24
Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand
Seite: 1 | 2 | ►

Jetzt neu: